Drug Trial Radar · NCT02516046
18F-AV-1451 Autopsy Study
Last checked: Nov 20, 2026Latest source record: Sep 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
156
Actual
Start
Sep 2015
Primary completion
Jun 13, 2018
Study completion Jul 15, 2018
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Aug 5, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to test the relationship between ante-mortem flortaucipir Positron Emission Tomography (PET) imaging and tau neurofibrillary pathology associated with Alzheimer's disease (AD), as measured at autopsy.
Conditions
- Alzheimer's Disease
Interventions
Flortaucipir F18Drug
370 megabecquerel (MBq) IV single-dose
PET ScanProcedure
positron emission tomography (PET) scan
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Outcome 1: Diagnostic Performance of Individual Readers (NFT Score)Time frame: at autopsy within 9 months of baseline scan
- Primary Outcome 2: Diagnostic Performance of Individual Readers (NIA-AA Autopsy Diagnosis)Time frame: at autopsy within 9 months of baseline scan
Locations
31 sites in 2 countries. Site status is shown where the registry gives one.
Banner Alzheimer's Institute
Phoenix, Arizona
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Cherlin Research
Los Gatos, California
Hoag Memorial Hospital Presbyterian
Newport Beach, California
California Research Foundation
San Diego, California
Pacific Research Network
San Diego, California
Ray Dolby Brain Health Center
San Francisco, California
Syrentis Clinical Research
Santa Ana, California
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida
Galiz Research
Hialeah, Florida
Merritt Island Medical Research
Merritt Island, Florida
Miami Jewish Health Systems
Miami, Florida
D de la Vega MD Research Group
Miami, Florida
Bioclinica
Orlando, Florida
Emory University Brain Health Center
Atlanta, Georgia
Alzheimer's Disease Center
Quincy, Massachusetts
Steinberg Diagnostics
Henderson, Nevada
Adirondack Medical Research Center
Glens Falls, New York
Clarity Clinical Research, LLC
Syracuse, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest School of Medicine
Winston-Salem, North Carolina
Valley Medical Primary Care
Centerville, Ohio
Hospice of the Western Reserve
Cleveland, Ohio
American Clinical Trials, LLC (Site 1216)
Oklahoma City, Oklahoma
Oklahoma Behavioral Health
Oklahoma City, Oklahoma
Rhode Island Hospital
Providence, Rhode Island
Houston Methodist Research Institute
Houston, Texas
Sante Clinical Research
Kerrville, Texas
Overlake Internal Medicine Associates, PS
Bellevue, Washington
University of Washington Medicine
Seattle, Washington
University of Melbourne
Parkville, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.